Related Experiment Video
Updated: Jun 4, 2025

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Targeting kallikrein proteases for dandruff therapy
Hendra Wijaya Wong1, Ivan Kurniadi1, Kris Herawan Timotius2
1Department of Dermatology and Venereology, Faculty of Medicine and Health Sciences, Christian University of Krida Wacana, Jakarta, Indonesia.
Kallikrein proteases (KPs) are key enzymes in scalp health. Inhibiting overactive KPs, like human kallikrein (hK) 5 and hK7, offers a promising therapeutic strategy for dandruff treatment.
Area of Science:
- Biochemistry
- Dermatology
- Enzymology
Background:
- Kallikrein proteases (KPs) are essential enzymes regulating scalp desquamation.
- The balance between KPs (hK5, hK7) and their inhibitor LEKTI is crucial for a healthy scalp.
- Dysregulation, particularly insufficient LEKTI, leads to abnormal desquamation and dandruff.
Purpose of the Study:
- To review the role of KPs in dandruff pathogenesis.
- To evaluate the therapeutic potential of KP inhibitors for dandruff management.
Main Methods:
- Literature review analyzing KPs, dandruff, and inhibitors.
- Focus on human kallikrein (hK) 5 and hK7 and their inhibitor LEKTI.
Main Results:
- KPs, specifically hK5 and hK7, are implicated in abnormal desquamation.
- KP inhibitors demonstrate potential for reducing dandruff-related flake formation.
Conclusions:
- KPs are significant targets for novel dandruff treatments.
- KP inhibitor-based therapies offer a promising approach to managing dandruff by targeting protease activity.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Inhibition of Cdk Activity

